Michael Müller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Müller has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Mehdi Shajari
2 shared publications- Thomas Kohnen
Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany
2 shared publications - Adam Strzelczyk
Epilepsy Center Frankfurt Rhine‐Main, Department of Neurology Goethe‐University Frankfurt Frankfurt am Main Germany
1 shared publication - Andrea Spyrantis
Goethe University Frankfurt, Epilepsy Center Frankfurt Rhine‐Main, Department of Neurosurgery University Hospital Frankfurt Frankfurt Germany
1 shared publication Bernd Genser
Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
1 shared publicationBoris Malyugin
1 shared publication
Latest Publications
- Open Access
- 21 September 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 161, 110061
Impact of seizure outcome and extent of neocortical resection on emotional well-being in patients with epilepsy one year after temporal lobe surgery
- 21 September 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 161, 110061
Open AccessImpact of seizure outcome and extent of neocortical resection on emotional well-being in patients with epilepsy one year after temporal lobe surgery
- 18 May 2023
- Published by Springer Nature
- p. 533-541
Cataract Surgery in Special Circumstances—PEX and Zonular Weakness
- 18 May 2023
- Published by Springer Nature
- p. 533-541
Cataract Surgery in Special Circumstances—PEX and Zonular Weakness
- 31 March 2023
- Published by Springer Nature
- p. 285-287
Kataraktoperationen unter besonderen Umständen: Instabiler Halteapparat und Pseudoexfoliationssyndrom
- 31 March 2023
- Published by Springer Nature
- p. 285-287
Kataraktoperationen unter besonderen Umständen: Instabiler Halteapparat und Pseudoexfoliationssyndrom
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (6) , 667-672
Intraoperative OCT vs Scheimpflug and swept-source OCT measurements for anterior eye parameters
Purpose: To compare agreement of anterior segment parameter measurements using an intraoperative optical coherence tomography (iOCT) of a femtosecond laser (LenSx) during interface docking to the eye with preoperative Scheimpflug tomography (Pentacam AXL) and swept-source optical coherence tomography (SS-OCT) (IOLMaster 700). Setting: Department of Ophthalmology, Goethe University, Frankfurt, Germany. Design: Retrospective study. Methods: Anterior segment measurements were performed in mydriasis prior to surgery using Scheimpflug tomography and SS-OCT. Postoperatively, iOCT images were analyzed using a modification of the FIJI image-processing program. Outcome measures included external anterior chamber depth (ACD), central corneal thickness (CCT), and central lens thickness (LT). Results: 95 eyes of 66 patients who underwent planned OCT guided femtosecond laser-assisted lens surgery were included. The ACD measured with the iOCT was −0.011 ± 0.126 mm smaller (P = .389) than that with the SS-OCT and −0.059 ± 0.185 mm than with the Scheimpflug tomography (P = .003). The SS-OCT measured a −0.047 ± 0.146 mm smaller ACD than the Scheimpflug tomography (P = .002). The measurements of CCT using the iOCT and the Scheimpflug tomography (−0.705 ± 20.837 μm, P = .742) and the LT measurements using SS-OCT and iOCT (−0.050 ± 0.089 mm, P < .001) showed no clinically relevant difference. Only the ACD between the iOCT and the Scheimpflug tomography showed a clinically relevant difference. Conclusions: The comparison of the anterior segment parameters of iOCT with SS-OCT showed no clinically relevant differences regarding the ACD and the LT. However, Scheimpflug tomography vs iOCT measured a small clinically relevant difference for ACD. The iOCT showed no clinically relevant differences in anterior segment parameters compared with the SS-OCT. A small clinically relevant difference for ACD was found in comparison with that of a Scheimpflug device.
- 1 June 2022
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (6) , 667-672
Intraoperative OCT vs Scheimpflug and swept-source OCT measurements for anterior eye parameters
Purpose: To compare agreement of anterior segment parameter measurements using an intraoperative optical coherence tomography (iOCT) of a femtosecond laser (LenSx) during interface docking to the eye with preoperative Scheimpflug tomography (Pentacam AXL) and swept-source optical coherence tomography (SS-OCT) (IOLMaster 700). Setting: Department of Ophthalmology, Goethe University, Frankfurt, Germany. Design: Retrospective study. Methods: Anterior segment measurements were performed in mydriasis prior to surgery using Scheimpflug tomography and SS-OCT. Postoperatively, iOCT images were analyzed using a modification of the FIJI image-processing program. Outcome measures included external anterior chamber depth (ACD), central corneal thickness (CCT), and central lens thickness (LT). Results: 95 eyes of 66 patients who underwent planned OCT guided femtosecond laser-assisted lens surgery were included. The ACD measured with the iOCT was −0.011 ± 0.126 mm smaller (P = .389) than that with the SS-OCT and −0.059 ± 0.185 mm than with the Scheimpflug tomography (P = .003). The SS-OCT measured a −0.047 ± 0.146 mm smaller ACD than the Scheimpflug tomography (P = .002). The measurements of CCT using the iOCT and the Scheimpflug tomography (−0.705 ± 20.837 μm, P = .742) and the LT measurements using SS-OCT and iOCT (−0.050 ± 0.089 mm, P < .001) showed no clinically relevant difference. Only the ACD between the iOCT and the Scheimpflug tomography showed a clinically relevant difference. Conclusions: The comparison of the anterior segment parameters of iOCT with SS-OCT showed no clinically relevant differences regarding the ACD and the LT. However, Scheimpflug tomography vs iOCT measured a small clinically relevant difference for ACD. The iOCT showed no clinically relevant differences in anterior segment parameters compared with the SS-OCT. A small clinically relevant difference for ACD was found in comparison with that of a Scheimpflug device.
- Open Access
- 11 February 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 26, 101407
Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
- 11 February 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 26, 101407
Open AccessOphthalmic artery occlusion after glabellar hyaluronic acid filler injection
- Open Access
- 25 August 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
There is limited knowledge on the prevalence and risk factors of diabetic retinopathy (DR) in dialysis patients. We have investigated the association between diabetes mellitus and lipid-related biomarkers and retinopathy in hemodialysis patients. We reviewed 1,255 hemodialysis patients with type 2 diabetes mellitus (T2DM) who participated in the German Diabetes and Dialysis Study (4D Study). Associations between categorical clinical, biochemical variables and diabetic retinopathy were examined by logistic regression. On average, patients were 66 ± 8 years of age, 54% were male and the HbA1c was 6.7% ± 1.3%. DR, found in 71% of the patients, was significantly and positively associated with fasting glucose, HbA1c, time on dialysis, age, systolic blood pressure, body mass index and the prevalence of other microvascular diseases (e.g. neuropathy). Unexpectedly, DR was associated with high HDL cholesterol and high apolipoproteins AI and AII. Patients with coronary artery disease were less likely to have DR. DR was not associated with gender, smoking, diastolic blood pressure, VLDL cholesterol, triglycerides, and LDL cholesterol. In summary, the prevalence of DR in patients with type 2 diabetes mellitus requiring hemodialysis is higher than in patients suffering from T2DM, who do not receive hemodialysis. DR was positively related to systolic blood pressure (BP), glucometabolic control, and, paradoxically, HDL cholesterol. This data suggests that glucose and blood pressure control may delay the development of DR in patients with diabetes mellitus on dialysis.
- 25 August 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Open AccessRisk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
There is limited knowledge on the prevalence and risk factors of diabetic retinopathy (DR) in dialysis patients. We have investigated the association between diabetes mellitus and lipid-related biomarkers and retinopathy in hemodialysis patients. We reviewed 1,255 hemodialysis patients with type 2 diabetes mellitus (T2DM) who participated in the German Diabetes and Dialysis Study (4D Study). Associations between categorical clinical, biochemical variables and diabetic retinopathy were examined by logistic regression. On average, patients were 66 ± 8 years of age, 54% were male and the HbA1c was 6.7% ± 1.3%. DR, found in 71% of the patients, was significantly and positively associated with fasting glucose, HbA1c, time on dialysis, age, systolic blood pressure, body mass index and the prevalence of other microvascular diseases (e.g. neuropathy). Unexpectedly, DR was associated with high HDL cholesterol and high apolipoproteins AI and AII. Patients with coronary artery disease were less likely to have DR. DR was not associated with gender, smoking, diastolic blood pressure, VLDL cholesterol, triglycerides, and LDL cholesterol. In summary, the prevalence of DR in patients with type 2 diabetes mellitus requiring hemodialysis is higher than in patients suffering from T2DM, who do not receive hemodialysis. DR was positively related to systolic blood pressure (BP), glucometabolic control, and, paradoxically, HDL cholesterol. This data suggests that glucose and blood pressure control may delay the development of DR in patients with diabetes mellitus on dialysis.